PetMed Express, Inc. (NASDAQ:PETS) Shares Sold by Hotchkis & Wiley Capital Management LLC

Hotchkis & Wiley Capital Management LLC cut its stake in PetMed Express, Inc. (NASDAQ:PETS) by 15.8% during the 3rd quarter, HoldingsChannel reports. The fund owned 1,090,703 shares of the company’s stock after selling 204,590 shares during the period. Hotchkis & Wiley Capital Management LLC owned about 0.05% of PetMed Express worth $4,014,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Point72 DIFC Ltd acquired a new stake in PetMed Express in the second quarter valued at $34,000. Marshall Wace LLP acquired a new stake in PetMed Express in the second quarter valued at $46,000. SG Americas Securities LLC acquired a new stake in shares of PetMed Express during the second quarter worth $46,000. Legacy Advisors LLC acquired a new stake in shares of PetMed Express during the second quarter worth $96,000. Finally, Independent Advisor Alliance acquired a new stake in shares of PetMed Express during the third quarter worth $106,000. 73.33% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of PetMed Express from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th.

PetMed Express Stock Performance

Shares of NASDAQ:PETS opened at $5.31 on Friday. The stock has a market capitalization of $109.70 million, a price-to-earnings ratio of -88.50 and a beta of 0.71. PetMed Express, Inc. has a 1-year low of $2.90 and a 1-year high of $7.90. The company’s fifty day moving average is $4.38 and its two-hundred day moving average is $3.98.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.17. The business had revenue of $59.57 million during the quarter, compared to analyst estimates of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. Sell-side analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current fiscal year.

Insider Transactions at PetMed Express

In related news, major shareholder Nina Capital Holdings Inc. bought 12,500 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was purchased at an average price of $3.34 per share, for a total transaction of $41,750.00. Following the transaction, the insider now directly owns 2,078,000 shares of the company’s stock, valued at approximately $6,940,520. This represents a 0.61 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.10% of the company’s stock.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.